RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 14, 2020

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Major Depression
Interventions
DRUG

XingpiJieyu formula

XingpiJieyu formula is a traditional Chinese medicine. It pays attention to the regulation of qi and blood. Previous studies have shown that its clinical effect of treating mild and moderate depression is significant, for example, it can effectively improve depressive mood and somatic symptoms, and increase peripheral blood ATP levels in patients with depression.

DRUG

Placebo

Placebo, no therapeutic effect.

DRUG

Escitalopram

A commonly used drug in MDD treatment.

Trial Locations (1)

100191

Peking University Sixth Hospital, Beijing

All Listed Sponsors
lead

Peking University Sixth Hospital

OTHER

NCT06758167 - RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD | Biotech Hunter | Biotech Hunter